Skip to main content
. 2011 Apr 20;2:21. doi: 10.3389/fphar.2011.00021

Figure 2.

Figure 2

Therapeutic approach for pulmonary arterial hypertension (PAH) based on the WHO functional class. CCB, calcium channel blocker.